These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 2888038)
1. Effects of apomorphine and (+/-)-3-(3-hydroxyphenyl)-N-n-propylpiperidine, injected into the striatum, on the caudate spindle in the rat. Hashimoto S; Okuyama S; Aihara H Neuropharmacology; 1987 Jul; 26(7A):663-7. PubMed ID: 2888038 [TBL] [Abstract][Full Text] [Related]
2. Relative selectivity of 6,7-dihydroxy-2-dimethylaminotetralin, N-n-propyl-3-(3-hydroxyphenyl)piperidine, N-n-propylnorapomorphine and pergolide as agonists at striatal dopamine autoreceptors and postsynaptic dopamine receptors. Claustre Y; Fage D; Zivkovic B; Scatton B J Pharmacol Exp Ther; 1985 Feb; 232(2):519-25. PubMed ID: 2857197 [TBL] [Abstract][Full Text] [Related]
3. Differential effects of the enantiomers of 3-(3-hydroxyphenyl)-N-n-propylpiperidine (3-PPP) at dopamine receptor sites. Koch SW; Koe BK; Bacopoulos NG Eur J Pharmacol; 1983 Sep; 92(3-4):279-83. PubMed ID: 6138267 [TBL] [Abstract][Full Text] [Related]
4. 7-[3-(4-[2,3-Dimethylphenyl]piperazinyl)propoxy]-2(1H)-quinolinone (OPC-4392), a presynaptic dopamine autoreceptor agonist and postsynaptic D2 receptor antagonist. Yasuda Y; Kikuchi T; Suzuki S; Tsutsui M; Yamada K; Hiyama T Life Sci; 1988; 42(20):1941-54. PubMed ID: 3130534 [TBL] [Abstract][Full Text] [Related]
5. (+)- and (-)-3-PPP exhibit different intrinsic activity at striatal dopamine autoreceptors controlling dopamine synthesis. Clark D; Hjorth S; Carlsson A Eur J Pharmacol; 1984 Oct; 106(1):185-9. PubMed ID: 6099268 [TBL] [Abstract][Full Text] [Related]
6. Dopamine agonists at repeated "autoreceptor-selective" doses: effects upon the sensitivity of A10 dopamine autoreceptors. Jeziorski M; White FJ Synapse; 1989; 4(4):267-80. PubMed ID: 2603146 [TBL] [Abstract][Full Text] [Related]
7. Lack of effect of intranigral administration of a dopamine analogue, (+/-)-3-(3-hydroxyphenyl)-N,n-propylpiperidine [(+/-)-3-PPP], on nigrostriatal dopamine neurones. Kelly E; Jenner P; Marsden CD Neurosci Lett; 1985 May; 56(1):57-62. PubMed ID: 4011049 [TBL] [Abstract][Full Text] [Related]
8. Enhancing effect of taurine on the rat caudate spindle. I: Interaction of taurine with the nigro-striatal dopamine system. Hashimoto-Kitsukawa S; Okuyama S; Aihara H Pharmacol Biochem Behav; 1988 Oct; 31(2):411-6. PubMed ID: 3244718 [TBL] [Abstract][Full Text] [Related]
9. Evidence for multiple dopamine receptors involved in the modulation of acetylcholine release in the striatum. Hársing LG; Vizi ES Pol J Pharmacol Pharm; 1985; 37(3):383-96. PubMed ID: 2866504 [TBL] [Abstract][Full Text] [Related]
10. Differential agonist profile of the enantiomers of 3-PPP at striatal dopamine autoreceptors: dependence on extracellular dopamine. Clark D; Salah RS; Galloway MP Synapse; 1991 Jul; 8(3):169-76. PubMed ID: 1948667 [TBL] [Abstract][Full Text] [Related]
11. D1 dopamine receptor stimulation enables the postsynaptic, but not autoreceptor, effects of D2 dopamine agonists in nigrostriatal and mesoaccumbens dopamine systems. Wachtel SR; Hu XT; Galloway MP; White FJ Synapse; 1989; 4(4):327-46. PubMed ID: 2532422 [TBL] [Abstract][Full Text] [Related]
12. An electrophysiological analysis of the actions of the 3-PPP enantiomers on the nigrostriatal dopamine system. Clark D; Engberg G; Pileblad E; Svensson TH; Carlsson A; Freeman AS; Bunney BS Naunyn Schmiedebergs Arch Pharmacol; 1985 Jun; 329(4):344-54. PubMed ID: 4033804 [TBL] [Abstract][Full Text] [Related]
13. Pharmacological profiles of the putative dopamine autoreceptor agonists 3-PPP and TL-99. Martin GE; Haubrich DR; Williams M Eur J Pharmacol; 1981 Nov; 76(1):15-23. PubMed ID: 7318920 [TBL] [Abstract][Full Text] [Related]
14. Low doses of apomorphine elicit two opposing influences on dopamine cell electrophysiology. Grace AA; Bunney BS Brain Res; 1985 May; 333(2):285-98. PubMed ID: 3995296 [TBL] [Abstract][Full Text] [Related]
15. Agonist and antagonist effects of 3-PPP enantiomers on functional dopamine autoreceptors and postsynaptic dopamine receptors in vitro. Mulder AH; Draper R; Sminia P; Schoffelmeer AN; Stoof JC Eur J Pharmacol; 1985 Jan; 107(3):291-7. PubMed ID: 3979429 [TBL] [Abstract][Full Text] [Related]
16. A behavioural study of the changes in the central nervous system of mice after subchronic treatment with the selective dopamine autoreceptor agonist 3-PPP (dl-3-[3-hydroxyphenyl]-N-n-propylpiperidine). Jackson D; Carlsson A; Hjorth S; Lindberg P J Neural Transm; 1982; 53(4):233-45. PubMed ID: 6286867 [TBL] [Abstract][Full Text] [Related]
17. Enhancing effect of taurine in the rat caudate spindle. II. Effect of bilateral 6-hydroxydopamine lesions of the nigro-striatal dopamine system. Hashimoto-Kitsukawa S; Okuyama S; Aihara H Pharmacol Biochem Behav; 1988 Oct; 31(2):417-23. PubMed ID: 3149745 [TBL] [Abstract][Full Text] [Related]
18. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation. Hu XT; White FJ Synapse; 1992 Mar; 10(3):206-16. PubMed ID: 1532677 [TBL] [Abstract][Full Text] [Related]
19. Postsynaptic dopamine agonistic effects of 3-PPP enantiomers revealed by bilateral 6-hydroxy-dopamine lesions and by chronic reserpine treatment in rats. Arnt J; Hyttel J J Neural Transm; 1984; 60(3-4):205-23. PubMed ID: 6441835 [TBL] [Abstract][Full Text] [Related]
20. Biphasic effects of some dopamine agonists on striatal acetylcholine concentrations. Waldmeier PC Eur J Pharmacol; 1983 May; 90(1):115-20. PubMed ID: 6873173 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]